cannabis sativa flower

Tikun Olam Europe's balanced botanical cannabis is a pharmaceutical-grade dried flower product derived from the *Cannabis sativa* plant, specifically the **Midnight** strain. It is characterized by a balanced ratio of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The drug exerts its therapeutic effects by interacting with the endocannabinoid system, primarily acting as a partial agonist at the cannabinoid type 1 (CB1) and type 2 (CB2) receptors. CB1 receptors are predominantly located in the central nervous system and mediate effects on pain perception, appetite, and nausea, while CB2 receptors are mainly found in the immune system and peripheral tissues, contributing to anti-inflammatory and immunomodulatory actions. This balanced profile is designed to provide symptomatic relief for chronic pain, spasticity (associated with conditions like multiple sclerosis), chemotherapy-induced nausea and vomiting (CINV), and appetite stimulation, while potentially mitigating the psychoactive intensity associated with high-THC strains. It is approved in Greece for these indications.

Brand names

MidnightTikun Midnight

Other names

medical cannabismedical marijuanadried cannabis flowercannabis flosTikun Olam Europe/Greece-CB1-CB2-botanical cannabis-dried flower-Chronic Pain-Spasticity-Nausea and Vomiting induced by chemotherapy/radiotherapy-Appetite Stimulation